Clinical trial
Imaging PARP Expression in Cholangiocarcinoma
NCT07673341 is registered in ClinicalTrials.gov with University of Washington as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Imaging PARP Expression in Cholangiocarcinoma
- Lead sponsor
- University of Washington
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- November 1, 2026
- Completion date
- December 31, 2028
- Enrollment
- 22 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.